
| Quantum Corporation | ||
(Exact name of registrant as specified in its charter) | ||
| Delaware | 001-13449 | 94-2665054 | |||||||||||||||
| (State or other jurisdiction of incorporation or organization) | (Commission File No.) | (I.R.S. Employer Identification No.) | |||||||||||||||
| 10770 E. Briarwood Avenue | |||||||||||||||||
| Centennial, | CO | 80112 | |||||||||||||||
| (Address of Principal Executive Offices) | (Zip Code) | ||||||||||||||||
| (408) | 944-4000 | ||||
| Registrant's telephone number, including area code | |||||
| N/A | |||||
| (Former name or former address, if changed since last report) | |||||
| Title of each class | Trading Symbol | Name of each exchange on which registered | ||||||||||||
| Common Stock, $0.01 par value per share | QMCO | Nasdaq Global Market | ||||||||||||
Exhibit No. |
Description |
|||||||
| 99.1 | ||||||||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). | |||||||
| Quantum Corporation | ||||||||||||||
| (Registrant) | ||||||||||||||
| June 25, 2026 | /s/ William H. White | |||||||||||||
| (Date) | William H. White | |||||||||||||
| Chief Financial Officer | ||||||||||||||

| March 31, | |||||||||||
| 2026 | 2025 | ||||||||||
| Assets | |||||||||||
| Current assets: | |||||||||||
| Cash and cash equivalents | $ 15,572 |
$ 16,464 |
|||||||||
| Restricted cash | 662 |
139 |
|||||||||
| Accounts receivable, net of allowance for credit losses of $3,234 and $99, respectively | 69,650 |
52,502 |
|||||||||
| Inventories | 16,103 |
22,434 |
|||||||||
| Prepaid expenses | 2,431 |
2,738 |
|||||||||
| Other current assets | 8,068 |
8,529 |
|||||||||
| Total current assets | 112,486 |
102,806 |
|||||||||
| Property and equipment, net | 9,284 |
11,378 |
|||||||||
| Intangible assets, net | — |
281 |
|||||||||
| Goodwill | 12,969 |
12,969 |
|||||||||
| Right-of-use assets, net | 7,416 |
8,580 |
|||||||||
| Other long-term assets | 14,737 |
19,388 |
|||||||||
| Total assets | $ 156,892 |
$ 155,402 |
|||||||||
| Liabilities and Stockholders’ Deficit | |||||||||||
| Current liabilities: | |||||||||||
| Accounts payable | $ 29,342 |
$ 31,463 |
|||||||||
| Accrued compensation | 11,862 |
9,214 |
|||||||||
| Deferred revenue, current portion | 75,654 |
75,076 |
|||||||||
| Accrued restructuring charges | 566 |
786 |
|||||||||
| Term debt | 54,811 |
96,486 |
|||||||||
| Revolving credit facility | — |
26,600 |
|||||||||
| Warrant liabilities | 14,105 |
— |
|||||||||
| Other accrued liabilities | 19,457 |
17,982 |
|||||||||
| Total current liabilities | 205,797 |
257,607 |
|||||||||
| Deferred revenue, net of current portion | 39,030 |
38,847 |
|||||||||
| Convertible note | 90,034 |
— |
|||||||||
| Operating lease liabilities | 8,172 |
8,934 |
|||||||||
| Other long-term liabilities | 12,716 |
14,380 |
|||||||||
| Total liabilities | 355,749 |
319,768 |
|||||||||
| Commitments and contingencies (Note 10) | |||||||||||
| Stockholders’ deficit | |||||||||||
| Preferred stock: | |||||||||||
| Preferred stock, 20,000 shares authorized; no shares issued as of March 31, 2026 and 2025, respectively | — |
— |
|||||||||
| Common stock: | |||||||||||
| Common stock, $0.01 par value; 225,000 shares authorized; 14,638 and 6,962 shares issued and outstanding at March 31, 2026 and 2025, respectively | 146 |
70 |
|||||||||
| Additional paid-in capital | 853,974 |
779,645 |
|||||||||
| Accumulated deficit | (1,043,517) |
(942,471) |
|||||||||
| Accumulated other comprehensive loss | (9,460) |
(1,610) |
|||||||||
| Total stockholders' deficit | (198,857) |
(164,366) |
|||||||||
| Total liabilities and stockholders' deficit | $ 156,892 |
$ 155,402 |
|||||||||
| Year Ended March 31, | |||||||||||
| 2026 | 2025 | ||||||||||
| Revenue | |||||||||||
| Product | $ 172,385 |
$ 154,182 |
|||||||||
| Service and subscription | 99,226 |
110,658 |
|||||||||
| Royalty | 7,970 |
9,218 |
|||||||||
| Total revenue | 279,581 |
274,058 |
|||||||||
| Cost of revenue | |||||||||||
| Product | 136,199 |
119,730 |
|||||||||
| Service and subscription | 40,341 |
44,496 |
|||||||||
| Total cost of revenue | 176,540 |
164,226 |
|||||||||
| Gross profit | 103,041 |
109,832 |
|||||||||
| Operating expenses | |||||||||||
| Sales and marketing | 52,016 |
52,320 |
|||||||||
| General and administrative | 43,917 |
63,961 |
|||||||||
| Research and development | 23,503 |
31,141 |
|||||||||
| Restructuring charges | 8,112 |
4,090 |
|||||||||
| Total operating expenses | 127,548 |
151,512 |
|||||||||
| Loss from operations | (24,507) |
(41,680) |
|||||||||
| Other expense, net | (1,511) |
(710) |
|||||||||
| Interest expense | (21,575) |
(23,607) |
|||||||||
| Change in fair value of warrant liability | 11,315 |
(45,270) |
|||||||||
| Change in fair value of convertible note | (4,119) |
— |
|||||||||
| Loss on debt extinguishment, net | (59,641) |
(3,003) |
|||||||||
| Loss before income taxes | (100,038) |
(114,270) |
|||||||||
| Income tax provision | 1,008 |
821 |
|||||||||
| Net loss | $ (101,046) |
$ (115,091) |
|||||||||
| Net loss per share - basic and diluted | $ (7.97) |
$ (22.35) |
|||||||||
| Weighted average shares - basic and diluted | 12,674 |
5,150 |
|||||||||
| Net loss | $ (101,046) |
$ (115,091) |
|||||||||
| Change in fair value of convertible note | (8,444) |
— |
|||||||||
| Foreign currency translation adjustments, net | 594 |
583 |
|||||||||
| Total comprehensive loss | $ (108,896) |
$ (114,508) |
|||||||||
| (in thousands) | Year Ended March 31, | ||||||||||
| 2026 | 2025 | ||||||||||
| Operating activities | |||||||||||
| Net loss | $ (101,046) |
$ (115,091) |
|||||||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||||||||
| Depreciation and amortization | 5,282 |
5,598 |
|||||||||
| Amortization of debt issuance costs | 6,613 |
5,475 |
|||||||||
| Non-cash lease expense | 1,277 |
1,606 |
|||||||||
| Paid-in-kind interest | 6,598 |
5,179 |
|||||||||
| Provision for manufacturing and service inventories | 5,333 |
4,877 |
|||||||||
| Bad debt expense | 2,733 |
77 |
|||||||||
| Stock-based compensation | (849) |
2,828 |
|||||||||
| Warrants issued in connection with debt amendments | 25,420 |
— |
|||||||||
| Change in fair value of warrant liabilities | (11,315) |
45,270 |
|||||||||
| Change in fair value of convertible note | 4,119 |
— |
|||||||||
| Non-cash loss on debt extinguishment | 34,221 |
3,003 |
|||||||||
| Other non-cash | (331) |
16 |
|||||||||
| Changes in assets and liabilities: | |||||||||||
| Accounts receivable | (19,881) |
15,209 |
|||||||||
| Inventories | 944 |
801 |
|||||||||
| Accounts payable | (793) |
6,154 |
|||||||||
| Prepaid expenses | 307 |
(552) |
|||||||||
| Operating lease liabilities | (931) |
(1,490) |
|||||||||
| Deferred revenue | 760 |
(2,764) |
|||||||||
| Accrued restructuring charges | (220) |
786 |
|||||||||
| Accrued compensation | 2,647 |
(9,000) |
|||||||||
| Other assets | 686 |
2,110 |
|||||||||
| Other liabilities | 570 |
6,295 |
|||||||||
| Net cash used in operating activities | (37,856) |
(23,613) |
|||||||||
| Investing activities | |||||||||||
| Purchases of property and equipment | (1,706) |
(4,947) |
|||||||||
| Net cash used in investing activities | (1,706) |
(4,947) |
|||||||||
| Financing activities | |||||||||||
| Borrowings of long-term debt, net of debt issuance costs | 45,045 |
25,000 |
|||||||||
| Borrowing of convertible note | 54,718 |
— |
|||||||||
| Repayment of long-term debt | — |
(19,129) |
|||||||||
| Repayments of long-term debt on Assignment | (52,270) |
— |
|||||||||
| Repayments of long-term debt on Exchange | (56,979) |
— |
|||||||||
| Borrowings of credit facility | 102,914 |
416,418 |
|||||||||
| Repayments of credit facility and payment of amendment fees | (129,514) |
(418,811) |
|||||||||
| Proceeds from shares related to the SEPA, net | 75,174 |
15,828 |
|||||||||
| Proceeds from issuance of common stock, net | 80 |
— |
|||||||||
| Net cash provided by financing activities | 39,168 |
19,306 |
|||||||||
| Effect of exchange rate changes on cash and cash equivalents | 25 |
(3) |
|||||||||
| Net change in cash, cash equivalents, and restricted cash | (369) |
(9,257) |
|||||||||
| Cash, cash equivalents, and restricted cash at beginning of year | 16,603 |
25,860 |
|||||||||
| Cash, cash equivalents, and restricted cash at end of year | $ 16,234 |
$ 16,603 |
|||||||||
| Supplemental disclosure of cash flow information | |||||||||||
| Cash paid for interest | $ 5,170 |
$ 11,927 |
|||||||||
| Cash paid for income taxes, net of refunds | $ 1,194 |
$ 1,814 |
|||||||||
| Non-cash transactions | |||||||||||
| Purchases of property and equipment included in accounts payable | $ 116 |
$ 850 |
|||||||||
| Right-of-use assets obtained in exchange for new lease liabilities | $ 112 |
$ 678 |
|||||||||
| Warrants issued | $ 25,420 |
$ — |
|||||||||
| The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the consolidated balance sheets that sum to the total of the same such amounts shown in the consolidated statements of cash flows: | |||||||||||
| Cash and cash equivalents | $ 15,572 |
$ 16,464 |
|||||||||
| Restricted cash | 662 |
139 |
|||||||||
| Total cash, cash equivalents and restricted cash at the end of year | $ 16,234 |
$ 16,603 |
|||||||||
| Quarter Ended March 31, | |||||||||||
| 2026 | 2025 | ||||||||||
| GAAP net loss | (9,541). | (7,744) | |||||||||
| Provision for income taxes | 38 |
146 |
|||||||||
| Interest expense, net | 2,899 |
6,847 |
|||||||||
| Depreciation and amortization expense | 1,208 |
1,627 |
|||||||||
| Stock-based compensation expense | 324 |
452 |
|||||||||
| Restructuring charges | 1,049 | 1,906 | |||||||||
| Fair value of warrants adjustment | (2,230) |
(11,145) |
|||||||||
| Fair value of convertible note adjustment | 5,718 |
0 |
|||||||||
| Non-recurring project costs | 1,573 |
3,974 |
|||||||||
| Adjusted EBITDA | 1,038 |
(3,937) |
|||||||||
| Quarter Ended March 31, | |||||||||||
| 2026 | 2025 | ||||||||||
| GAAP net loss | -9541 | (7,744) | |||||||||
| Depreciation and amortization expense | 1,208 |
1,627 |
|||||||||
| Stock-based compensation expense | 324 |
452 |
|||||||||
| Interest expense, net | 0 | 188 | |||||||||
| Restructuring | 1,049 | 1906 | |||||||||
| Fair value of warrants adjustment | (2,230) |
(11,145) |
|||||||||
| Fair value of convertible note adjustment | 5,718 |
0 |
|||||||||
| Non-recurring project costs | 1,573 |
3,974 |
|||||||||
| Non-GAAP adjusted net loss | 3,107 |
(12,140) |
|||||||||
| Non-GAAP adjusted net loss per share – basic and diluted | ($0.21) |
($1.98) |
|||||||||
| Weighted average shares – basic and diluted | 14,497 |
6,125 |
|||||||||
| Quarter Ended March 31, | |||||||||||
| 2026 | 2025 | ||||||||||
| GAAP cost of revenue | 50,149. | 37,021 | |||||||||
| Stock-based compensation expense | 12 |
(12) |
|||||||||
| Restructuring | 0 |
(157) |
|||||||||
| Non-GAAP cost of revenue | 50,161 | 36,851 | |||||||||
| Quarter Ended March 31, | |||||||||||
| 2026 | 2025 | ||||||||||
| GAAP Revenue | 77,994 | 61,262 | |||||||||
| Non-GAAP cost of revenue | 50,161 |
36,851 |
|||||||||
| Non-GAAP gross profit | 27,833 |
24,411 |
|||||||||
| Non-GAAP gross margin | 35.7 | % | 39.8 | % | |||||||
| Quarter Ended March 31, | |||||||||||
| 2026 | 2025 | ||||||||||
| GAAP operating expenses | 30,409 | 35,835 | |||||||||
| Stock-based compensation expense | 336 |
440 |
|||||||||
| Restructuring charges | 1,049 |
1,749 |
|||||||||
| Amortization of acquisition-related intangible assets | 0 |
228 |
|||||||||
| Non-recurring project costs | 1,573 |
3,974 |
|||||||||
| Non-GAAP operating expenses | 27,451 | 29,443 | |||||||||